Obagi
FDA Label NDC 62032-160

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Obagi Cosmeceuticals Llc for the product Obagi (NDC 62032-160). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, otc - purpose, uses, warnings, directions, other information, inactive ingredients, questions or comments?, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Drug Facts

Distributed by Obagi Cosmeceuticals LLC,
Long Beach, CA 90806

Otc - Purpose

Active ingredientsPurpose

Homosalate 10%

Octinoxate 7.5%

Titanium dioxide 3.22%

Sunscreen

Sunscreen

Sunscreen

Zinc oxide 5%

Sunscreen

Uses

  • ▪helps prevent sunburn
  • ▪if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

  • For external use only
  • Do not use on damaged or broken skin
  • When using this product keep out of eyes. Rinse with water to remove.
  • Stop use and ask a doctor if rash occurs
  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • ▪apply liberally 15 minutes before sun exposure
  • ▪use a water resistant sunscreen if swimming or sweating
  • ▪reapply at least every 2 hours
  • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
    • ▪limit time in the sun, especially from 10 a.m.-2 p.m.
    • ▪wear long-sleeved shirts, pants, hats and sunglasses
    • ▪children under 6 months: ask a doctor

Other Information

  • ▪store at controlled room temperature: 15°C–25°C (59°F–77°F)
  • ▪protect this product from excessive heat and direct sun

Inactive Ingredients

Water, Butyloctyl Salicylate, Caprylic/Capric Triglyceride, Caprylyl Methicone, Polyglyceryl-10 Pentastearate, Butylene Glycol, Glyceryl Stearate, PEG-100 Stearate, Pentylene Glycol, Behenyl Alcohol, Physalis Angulata Extract, Dimethicone, PEG-40 Stearate, Phenoxyethanol, Lithothamnion Calcareum Powder, Glycerin, Mica, Sodium Stearoyl Lactylate, Polyhydroxystearic Acid, Mannitol, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Citric Acid, Squalane, Xanthan Gum, Alumina, Stearic Acid, Diatomaceous Earth, Sodium Polyacrylate, Disodium EDTA, Ethylhexylglycerin, Synthetic Fluorphlogopite, Polysorbate 60, Zinc Sulfate, Sorbitan Oleate, Chlorphenesin, Tetrahexyldecyl Ascorbate, Tocopherol, Tin Oxide, Iron Oxides

Questions Or Comments?

1.800.636.7546

Monday–Friday 9 a.m.–4 p.m. Pacific Time

Principal Display Panel - 85 G Tube Carton

OBAGI
MEDICAL

Sun Shield

Broad
Spectrum
SPF 50
Sunscreen
Lotion

WARM
TINT

Infrared
Defense

Non-comedogenic
Dermatologist tested

Net wt. 3 oz. (85 g)

Principal Display Panel (85 g Tube Carton)

Principal Display Panel (85 g Tube Carton)

* Please review the disclaimer below.